Features of chronic urticaria after COVID-19 mRNA vaccine over time.

Autor: Schwab J; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Foglierini M; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Biomedical Data Science Centre (BDSC) Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Pescosolido E; Centro Pediatrico del Mendrisiotto, Mendrisio, Switzerland., Pacheco I; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Ruiz Buendía GA; Centre of Vaccinology, University of Geneva, Geneva, Switzerland.; Translational Data Science Facility, AGORA Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Madelon N; Centre of Vaccinology, University of Geneva, Geneva, Switzerland., Pellaton C; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Banderet V; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Ribi C; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Bergmann MM; Centro Pediatrico del Mendrisiotto, Mendrisio, Switzerland.; Faculty of Biomedical Science, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Pediatric Allergy Unit, Department of Women, Children and Adolescents, University Hospitals of Geneva, Geneva, Switzerland., Didierlaurent AM; Centre of Vaccinology, University of Geneva, Geneva, Switzerland., Fenwick C; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Duperrex O; Center for Primary Care and Public Health (Unisanté) and University of Lausanne, Lausanne, Switzerland., Muller YD; Division of Immunology and Allergy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. Yannick.muller@chuv.ch.; Centre for Human Immunology Lausanne, Lausanne, Switzerland. Yannick.muller@chuv.ch.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Nov 30; Vol. 4 (1), pp. 254. Date of Electronic Publication: 2024 Nov 30.

Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.

Autor: Pescosolido E; Centro Pediatrico del Mendrisiotto, Mendrisio, Switzerland., Muller YD; Service d'Immunologie et Allergie, CHUV, Lausanne, Switzerland., Sabaté-Brescó M; Allergy Department, Clínica Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain., Ferrer M; Allergy Department, Clínica Universidad de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain., Yerly D; Adverse Drug Reactions - Analysis and Consulting, Bern, Switzerland., Caubet JC; Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland., Lantin JP; Clinica Luganese Moncucco, Lugano, Switzerland., Ribi C; Service d'Immunologie et Allergie, CHUV, Lausanne, Switzerland., Bergmann MM; Centro Pediatrico del Mendrisiotto, Mendrisio, Switzerland.; Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland.; Faculty of Biomedical Science, Università della Svizzera Italiana (USI), Lugano, Switzerland.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Nov; Vol. 52 (11), pp. 1343-1346. Date of Electronic Publication: 2022 Aug 23.

Comprehensive Review of the Latest Investigations of the Health-Enhancing Effects of Selected Properties of Arthrospira and Spirulina Microalgae on Skin.

Autor: Chwil, Mirosława¹ (AUTHOR) miroslawa.chwil@up.lublin.pl, Mihelič, Rok² (AUTHOR) rok.mihelic@bf.uni-lj.si, Matraszek-Gawron, Renata¹ (AUTHOR) miroslawa.chwil@up.lublin.pl, Terlecka, Paulina³ (AUTHOR) paulina.chwil@gmail.com, Skoczylas, Michał M.⁴ (AUTHOR) emes@e-post.pl, Terlecki, Karol⁵ (AUTHOR) karol.terlecki@umlub.pl

Publikováno v: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1321. 37p.

How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19.

Autor: Kocatürk, Emek^1,2,3 (AUTHOR) daniel.elieh-ali-komi@charite.de, Muñoz, Melba^2,3 (AUTHOR), Elieh-Ali-Komi, Daniel^2,3 (AUTHOR), Criado, Paulo Ricardo⁴ (AUTHOR), Peter, Jonny⁵ (AUTHOR), Kolkhir, Pavel^1,2 (AUTHOR), Can, Pelin⁶ (AUTHOR) pulkumen@gmail.com, Wedi, Bettina⁷ (AUTHOR), Rudenko, Michael⁸ (AUTHOR), Gotua, Maia⁹ (AUTHOR), Ensina, Luis Felipe¹⁰ (AUTHOR), Grattan, Clive¹¹ (AUTHOR), Maurer, Marcus^1,2 (AUTHOR) marcus.maurer@charite.de

Publikováno v: Viruses (1999-4915). Jul2023, Vol. 15 Issue 7, p1585. 24p.

Network advantage: Uncontested structural holes and organizational performance in market crises.

Autor: Shipilov, Andrew¹ (AUTHOR) shipilov@insead.edu, Li, Stan X.² (AUTHOR), Bothner, Matthew S.³ (AUTHOR), Truong, Nghi⁴ (AUTHOR)

Publikováno v: Strategic Management Journal (John Wiley & Sons, Inc.). Dec2023, Vol. 44 Issue 13, p3122-3154. 33p.